Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia

Abstract

Blocked cellular differentiation is a critical pathologic hallmark of acute myeloid leukemia (AML). Here, we showed that genetic activation of the orphan GPCR GPR132 significantly induced cell differentiation of AML both in vitro and in vivo, indicating that GPR132 is a potential trigger of myeloid differentiation. To explore the therapeutic potential of GPR132 signaling, we screened and validated a natural product 8-gingerol (8GL) as a GPR132 agonist. Notably, GPR132 activation by 8GL promoted differentiation and reduced colony formation in human AML cell lines with diverse genetic profiles. Mechanistic studies revealed that 8GL treatment inhibits the activation of the mammalian target of rapamycin (mTOR), a regulator of AML cell differentiation blockade, via activating GPR132-Gs-PKA pathway. We further showed that the combination of 8GL and an mTOR inhibitor synergistically elicited AML cell differentiation in vitro. Importantly, 8GL alone or in combination with an mTOR inhibitor remarkably impaired tumor growth and extended mouse survival in an AML xenograft model accompanied by enhanced cell differentiation. Notably, genetic or pharmacological activation of GPR132 triggered the differentiation of human primary AML cells. In summary, this study demonstrated that activation of orphan GPR132 represents a potential strategy for inducing myeloid differentiation in AML patients.

Super-enhancer-associated gene CAPG promotes AML progression

“…CD207 is a glycosylated receptor that acts as a specific receptor of Langerhans cells, processing of antigen for presentation to T cells 48 . GPR132 is a leukemia orphan receptor that has the potential to trigger myeloid differentiation 49 . In acute myeloid leukemia patients, high expression of SLC7A11 is associated with poor prognosis 50 , 51 .…”

Pathomics models based on H&E slides to predict the survival prognosis of patients with head and neck squamous cell carcinoma

“…Prior studies have shown that the inhibition of the mTOR signaling pathway can promote tumor cell differentiation 23 . mTOR inhibitors, such as rapamycin and its derivatives, have been used to promote the differentiation of certain tumor cells and have shown therapeutic effects, possibly by affecting transcription factors, cell cycle regulation, and cell signaling in tumor cells 24 .…”

Discovery of 2H-Indazole-3-carboxamide Derivatives as Novel Potent Prostanoid EP4 Receptor Antagonists for Colorectal Cancer Immunotherapy

“…HEK293 cells were cotransfected with 0.5 μg of EP4-Tango, 1.0 μg of β-arrestin-TEV, and 1.0 μg of tTA-Luc plasmid using PEI as the transfection reagent in a 6.0 cm dish . Transfected cells were seeded into 96-well plates (3.0 × 10 4 cells/well) and incubated at 37 °C overnight.…”